Our results confirm that deaths from COVID-19 were higher in patients with multiple comorbidities, a consequence of a pre-existing inflammatory state in chronic diseases and greater susceptibility to a cellular immune response and humoral activation, predominantly of tumor necrosis factor and interleukin 6 [35, 36]. Here, IL6 is linked to COVID-19.